Drugs / Mandarin Oil
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05282706 | May 2022 → Sep 2025 | — | The University of Texas Health Science Center at San Antonio | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Mandarin Oil | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05282706 ↗ |
| Modality | Other / unclassified | “3 essential oils: lavender, mandarin and peppermint administered on an inhalation patch” NCT05282706 ↗ |
| Route | Inhaled | “administered on an inhalation patch” NCT05282706 ↗ |